Journal of the American Heart Association
Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events: A Cohort Study
Study in peopleInterventions
Papers by Neil A. Accortt
3 results
- AHA Scientific Sessions 2025 Abstract
Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
Study in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Use of a Principled Framework to Compare Cardiovascular Outcomes from the FOURIER Trial to a FOURIER like-External Control Arm Using Real-World Data
Study in peopleInterventions